Fulvestrant 68001-0522
Product NDC
68001-0522- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Injection
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- October 29, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA211689
Need to source Fulvestrant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fulvestrant | 250 mg/5mL |
Drug Class
Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonists [MoA]
Packaging Options(1)
2 SYRINGE, GLASS in 1 CARTON (68001-522-85) / 5 mL in 1 SYRINGE, GLASS (68001-522-86)